Literature DB >> 17124600

Differing distributions of CXCR3- and CCR4-positive cells among types of interstitial pneumonia associated with collagen vascular diseases.

Shigeki Shimizu1, Takeo Yoshinouchi, Takashi Niimi, Yuji Ohtsuki, Jiro Fujita, Hiroyoshi Maeda, Shigeki Sato, Ichiro Yamadori, Tadaaki Eimoto, Ryuzo Ueda.   

Abstract

Interstitial pneumonia (IP) is an important complication in collagen vascular diseases (CVDs). We examined the distribution of helper T cell subsets in lung biopsies of cases of IP associated with CVD (CVD-IP). The tissues from 27 CVD-IP patients with rheumatoid arthritis (RA), 8 with polymyositis or dermatomyositis (PM/DM), and 8 with systemic sclerosis (SSc) were compared with those from 10 patients with idiopathic pulmonary fibrosis (IPF) in our previous study. The expressions of CXCR3 and CCR4 (chemokine receptors associated in vitro with Th1 and Th2 cells, respectively) in the mononuclear infiltrate were analyzed immunohistochemically. The positive cells were semiquantified in fibrosing areas of the CVD-IP and IPF cases. The number of CXCR3-positive cells was significantly greater in RA-IP than in PM/DM-IP, SSc-IP, or IPF, whereas there were fewer CCR4-positive cells in RA-IP, PM/DM-IP, and SSc-IP than in IPF. The CXCR3-/CCR4-positive cells ratio was significantly higher in RA-IP and PM/DM-IP (but not in SSc-IP) than in IPF. These results support previous reports of the dominance of Th2 cells in some SSc-IP and IPF cases. However, Th1-type immune responses may predominate in RA-IP and PM/DM-IP. Our findings suggest that the pathogenesis of CVD-IPs differs with the helper T cell subset.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17124600     DOI: 10.1007/s00428-006-0330-2

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  41 in total

1.  Effect of D-penicillamine on pulmonary fibrosis in patients with systemic sclerosis.

Authors:  M Jinnin; H Ihn; Y Asano; K Yamane; N Yazawa; K Tamaki
Journal:  Ann Rheum Dis       Date:  2003-10       Impact factor: 19.103

Review 2.  Pulmonary pathology in patients with systemic autoimmune diseases.

Authors:  T V Colby
Journal:  Clin Chest Med       Date:  1998-12       Impact factor: 2.878

Review 3.  Pulmonary involvement in the collagen vascular diseases.

Authors:  G W Hunninghake; A S Fauci
Journal:  Am Rev Respir Dis       Date:  1979-03

4.  The appearance of S-100 protein-positive dendritic cells and the distribution of lymphocyte subsets in idiopathic nonspecific interstitial pneumonia.

Authors:  S Shimizu; T Yoshinouchi; Y Ohtsuki; J Fujita; Y Sugiura; S Banno; I Yamadori; T Eimoto; R Ueda
Journal:  Respir Med       Date:  2002-10       Impact factor: 3.415

5.  Rules of chemokine receptor association with T cell polarization in vivo.

Authors:  C H Kim; L Rott; E J Kunkel; M C Genovese; D P Andrew; L Wu; E C Butcher
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

6.  Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis.

Authors:  E H Kang; E B Lee; K C Shin; C H Im; D H Chung; S K Han; Y W Song
Journal:  Rheumatology (Oxford)       Date:  2005-06-21       Impact factor: 7.580

7.  Role of the chemokine receptors CXCR3 and CCR4 in human pulmonary fibrosis.

Authors:  Patrizia Pignatti; Giuseppe Brunetti; Dania Moretto; Mona-Rita Yacoub; Marco Fiori; Bruno Balbi; Antonella Balestrino; Gabriella Cervio; Stefano Nava; Gianna Moscato
Journal:  Am J Respir Crit Care Med       Date:  2005-10-20       Impact factor: 21.405

8.  The interstitial lung disease associated with rheumatoid arthritis: evidence for imbalance of helper T-lymphocyte subpopulations at sites of disease activity.

Authors:  B Balbi; E Cosulich; A Risso; O Sacco; E Balzano; G A Rossi
Journal:  Bull Eur Physiopathol Respir       Date:  1987 May-Jun

9.  Distribution of CXCR3- or CCR4-positive cells in interstitial pneumonia associated with primary Sjogren's syndrome.

Authors:  Shigeki Shimizu; Takeo Yoshinouchi; Taio Naniwa; Mikae Nakamura; Shigeki Sato; Yuji Ohtsuki; Jiro Fujita; Ichiro Yamadori; Tadaaki Eimoto; Ryuzo Ueda
Journal:  Virchows Arch       Date:  2004-09-10       Impact factor: 4.064

10.  Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s.

Authors:  R Bonecchi; G Bianchi; P P Bordignon; D D'Ambrosio; R Lang; A Borsatti; S Sozzani; P Allavena; P A Gray; A Mantovani; F Sinigaglia
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307

View more
  4 in total

Review 1.  Rheumatoid Arthritis-Associated Interstitial Lung Disease: Current Concepts.

Authors:  Yoel Brito; Marilyn K Glassberg; Dana P Ascherman
Journal:  Curr Rheumatol Rep       Date:  2017-11-09       Impact factor: 4.592

2.  A novel mechanism for CCR4 in the regulation of macrophage activation in bleomycin-induced pulmonary fibrosis.

Authors:  Glenda Trujillo; Erica C O'Connor; Steven L Kunkel; Cory M Hogaboam
Journal:  Am J Pathol       Date:  2008-04-10       Impact factor: 4.307

3.  Biomarkers of rheumatoid arthritis-associated interstitial lung disease.

Authors:  Juan Chen; Tracy J Doyle; Yongliang Liu; Rohit Aggarwal; Xiaoping Wang; Yonghong Shi; Sheng Xiang Ge; Heqing Huang; Qingyan Lin; Wen Liu; Yongjin Cai; Diane Koontz; Carl R Fuhrman; Maria F Golzarri; Yushi Liu; Hiroto Hatabu; Mizuki Nishino; Tetsuro Araki; Paul F Dellaripa; Chester V Oddis; Ivan O Rosas; Dana P Ascherman
Journal:  Arthritis Rheumatol       Date:  2015-01       Impact factor: 10.995

4.  Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis.

Authors:  Florian Weigold; Jeannine Günther; Moritz Pfeiffenberger; Otavio Cabral-Marques; Elise Siegert; Duska Dragun; Aurélie Philippe; Ann-Katrin Regensburger; Andreas Recke; Xinhua Yu; Frank Petersen; Rusan Catar; Robert Biesen; Falk Hiepe; Gerd R Burmester; Harald Heidecke; Gabriela Riemekasten
Journal:  Arthritis Res Ther       Date:  2018-03-22       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.